U.S. Pledges $1.2 Billion For Experimental Vaccine Doses

Watch VideoAs the race for a COVID-19 vaccine continues, the U.S. has pledged $1.2 billion to British drugmaker AstraZeneca to obtain 300 million experimental vaccine doses.

According to USA Today, clinical testing of the vaccine began in April, and the doses will begin arriving in the U.S. by October. The outlet reports that...